Shares of Boston Scientific Corp. BSX slid 1.03% to $103.10 Tuesday, on what proved to be an all-around positive trading ...

Boston Scientific Corp. closed 2.80% short of its 52-week high of $107.17, which the company achieved on February 5th.

The FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...

The latest edition of “GC Connections” presents an annual review of new developments in the field of gas chromatography ...

This review highlights the high performance liquid chromatography (HPLC), mass spectrometry (MS), chromatography data systems ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of those who did not respond to the latest cancer treatments, known as immune ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

MedTech Market. The global MedTech market is poised for significant expansion between 2025 and 2035, bolstered by continuous ...

Adam Guillette, president of the conservative watchdog group Accuracy in Media, stood beside a black mobile billboard parked ...

Boston Scientific leads in MedSurg and Cardiovascular with strong Q1 growth, solid margins, and smart acquisitions. Find out ...

Boston, MA — Clareo Plastic Surgery continues to set the standard for liposuction in Boston by offering carefully refined ...